Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_assertion type Assertion NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_head.
- NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_assertion description "[To increase the neutralizing antibody levels and subsequent protection from virus challenge, four strategies were evaluated: (a) coimmunization with a plasmid expressing Aotus GM-CSF gene; (b) coimmunization with a plasmid containing human immunostimulatory sequences (ISS); (c) coimmunization with both the GM-CSF gene and ISS; and (d) delivery of vaccine using the needle-free Biojector system.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_provenance.
- NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_assertion evidence source_evidence_literature NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_provenance.
- NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_assertion SIO_000772 14585337 NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_provenance.
- NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_assertion wasDerivedFrom befree-20140225 NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_provenance.
- NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_assertion wasGeneratedBy ECO_0000203 NP402999.RAeLxCMW4EiqdmOhi2ybvyP9j8o42ikjumI8KJ5j-1DMY130_provenance.